Analysen zu Novo Nordisk
| 29.04.24 | Novo Nordisk Neutral | UBS AG | |
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Novo Nordisk Outperform | Bernstein Research | |
| 26.03.24 | Novo Nordisk Neutral | UBS AG | |
| 25.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 18.03.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 11.03.24 | Novo Nordisk Neutral | UBS AG | |
| 08.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.03.24 | Novo Nordisk Neutral | UBS AG | |
| 01.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.02.24 | Novo Nordisk Neutral | UBS AG | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 14.02.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Halten | DZ BANK | |
| 01.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 01.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novo Nordisk Neutral | UBS AG | |
| 31.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.01.24 | Novo Nordisk Neutral | UBS AG | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.24 | Novo Nordisk Overweight | Barclays Capital | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novo Nordisk Neutral | UBS AG | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 30.12.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 30.12.25 | Reckitt Benckiser Neutral | JP Morgan Chase & Co. | |
| 30.12.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 30.12.25 | Danone Overweight | JP Morgan Chase & Co. | |
| 30.12.25 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 30.12.25 | Henkel vz. Underweight | JP Morgan Chase & Co. | |
| 30.12.25 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 30.12.25 | EVN kaufen | Erste Group Bank | |
| 30.12.25 | Apple Underweight | Barclays Capital | |
| 30.12.25 | Unilever Outperform | Bernstein Research | |
| 30.12.25 | Reckitt Benckiser Outperform | Bernstein Research | |
| 30.12.25 | Nestlé Market-Perform | Bernstein Research | |
| 30.12.25 | L'Oréal Market-Perform | Bernstein Research | |
| 30.12.25 | Henkel vz. Market-Perform | Bernstein Research | |
| 30.12.25 | Danone Market-Perform | Bernstein Research | |
| 30.12.25 | Beiersdorf Outperform | Bernstein Research | |
| 29.12.25 | NVIDIA Buy | UBS AG | |
| 29.12.25 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 29.12.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 29.12.25 | NVIDIA Outperform | Bernstein Research | |
| 29.12.25 | Tesla Outperform | RBC Capital Markets | |
| 23.12.25 | Philips Hold | Jefferies & Company Inc. | |
| 23.12.25 | Orsted Hold | Jefferies & Company Inc. | |
| 23.12.25 | Gerresheimer Buy | Jefferies & Company Inc. | |
| 23.12.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 23.12.25 | Novartis Overweight | JP Morgan Chase & Co. | |
| 23.12.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 23.12.25 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.12.25 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 22.12.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 22.12.25 | HelloFresh Halten | DZ BANK | |
| 22.12.25 | Gerresheimer Verkaufen | DZ BANK | |
| 22.12.25 | Tesla Outperform | RBC Capital Markets | |
| 22.12.25 | Stellantis Sector Perform | RBC Capital Markets | |
| 22.12.25 | HORNBACH Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.12.25 | T-Mobile US Market-Perform | Bernstein Research | |
| 22.12.25 | Boeing Outperform | Bernstein Research | |
| 22.12.25 | Airbus Outperform | Bernstein Research | |
| 19.12.25 | NVIDIA Outperform | Bernstein Research | |
| 19.12.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 19.12.25 | Tesla Buy | Deutsche Bank AG | |
| 19.12.25 | Nike Kaufen | DZ BANK | |
| 19.12.25 | Nike Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.12.25 | Nike Outperform | Bernstein Research | |
| 19.12.25 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 19.12.25 | EssilorLuxottica Buy | UBS AG | |
| 19.12.25 | BP Neutral | UBS AG | |
| 19.12.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 19.12.25 | HORNBACH Add | Baader Bank | |
| 19.12.25 | Boeing Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.